Skip to main content
. 2022 Aug 26;23(17):9669. doi: 10.3390/ijms23179669

Figure 1.

Figure 1

Human MIKO-1 reduces lung fibrosis in the lungs of mice 28 days after bleomycin administration. (A) Collagen deposition areas. Scale bars: 100 mm. (B) Fibrosis scores. (C) Collagen contents. Data are shown as mean ± SD (N = 10 mice per group). *** p < 0.001, significant differences between the linked groups. NS: not significant.